We are live on ! Find out more
THRN

Thorne Healthtech, Inc. Common Stock
THRN

Delisted

THRN was delisted on the 13th of October, 2023.

Back to rankings

45 hedge funds and large institutions have $17.3M invested in Thorne Healthtech, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

2% more funds holding

Funds holding: 44 → 45 (+1)

7% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 14

34% less capital invested

Capital invested by funds: $26.2M → $17.3M (-$8.95M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
15
Reduced
14
Closed
6
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1M
2
MA
MYDA Advisors
New York
+$665K
3
BlackRock
BlackRock
New York
+$217K
4
Bank of America
Bank of America
North Carolina
+$191K
5
Millennium Management
Millennium Management
New York
+$133K

Top Sellers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
-$4.83M
2
SI
Scout Investments
Missouri
-$899K
3
Ameriprise
Ameriprise
Minnesota
-$458K
4
MAM
Martingale Asset Management
Massachusetts
-$76K
5
Morgan Stanley
Morgan Stanley
New York
-$50.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$44K – – –
Tudor Investment Corp
27
Tudor Investment Corp
Connecticut
$40K – – –
N
28
Nuveen
North Carolina
$38K – – –
Barclays
29
Barclays
United Kingdom
$37.3K +$13.8K +3,109 +43%
Deutsche Bank
30
Deutsche Bank
Germany
$30.7K +$417 +94 +1%
JP Morgan Chase
31
JP Morgan Chase
New York
$28K +$1.91K +431 +6%
AIG
32
American International Group
New York
$23.6K -$106 -24 -0.4%
Allspring Global Investments
33
Allspring Global Investments
North Carolina
$21.6K -$576 -130 -2%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$20K +$9.7K +2,188 +67%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$19.9K +$270 +61 +1%
TRCT
36
Tower Research Capital (TRC)
New York
$13K +$3.27K +738 +27%
UBS Group
37
UBS Group
Switzerland
$7.8K +$9.52K +2,148 New
US Bancorp
38
US Bancorp
Minnesota
$7.26K – – –
AB
39
Amalgamated Bank
New York
$7K – – –
Legal & General Group
40
Legal & General Group
United Kingdom
$5.17K – – –
AIP
41
Ameritas Investment Partners
Nebraska
$2.12K – – –
Fidelity Investments
42
Fidelity Investments
Massachusetts
$436 -$1.76K -396 -77%
Citigroup
43
Citigroup
New York
$341 -$514 -116 -55%
Dimensional Fund Advisors
44
Dimensional Fund Advisors
Texas
$82 +$100K +22,546 New
CS
45
Credit Suisse
Switzerland
$4 -$333 -75 -99%
DCM
46
Driehaus Capital Management
Illinois
– -$4.83M -1,020,098 Closed
MAM
47
Martingale Asset Management
Massachusetts
– -$76K -16,024 Closed
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
– -$50K -10,646 Closed
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
– -$13.7K -2,905 Closed
Wells Fargo
50
Wells Fargo
California
– -$1K -242 Closed
1
2

THRN Hedge Fund Activity: Q4 2022 in Review

45 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q4 2022, worth a combined $17.3M — down 34% from $26.2M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new THRN positions and 6 closed out — a net gain of 1 holder — while 15 added to existing stakes and 14 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $4.83M sold.

  • 45 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q4 2022, up from 44 in Q3 2022.
  • Funds reported $17.3M of Thorne Healthtech, Inc. Common Stock stock for Q4 2022, down 34% quarter-over-quarter.
  • 7 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q4 2022 and 6 closed out, a net change of +1 holder.
  • The largest Thorne Healthtech, Inc. Common Stock buyer in Q4 2022 was Vanguard Group, an estimated $1M added.
  • The largest Thorne Healthtech, Inc. Common Stock seller in Q4 2022 was Driehaus Capital Management, an estimated $4.83M sold.

Based on aggregated 13F filings for Q4 2022.